Phathom Pharmaceuticals (PHAT) PT Raised to $65 at Guggenheim

March 18, 2021 6:16 AM EDT
Get Alerts PHAT Hot Sheet
Price: $35.05 +0.78%

Rating Summary:
    6 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 0 | New: 25
Trade Now! 
Join SI Premium – FREE
Guggenheim analyst Yatin Suneja raised the price target on Phathom Pharmaceuticals (NASDAQ: PHAT) to $65.00 (from $60.00) while maintaining a Buy rating.

You May Also Be Interested In

Related Categories

Analyst PT Change